Axitinib in the treatment of renal cell carcinoma: design, development, and place in therapy

Audrey Bellesoeur, Edith Carton, Jerome Alexandre, Francois Goldwasser, Olivier Huillard Department of Medical Oncology, Hopital Cochin AP-HP, Paris, France Abstract: Since 2005, the approved first-line treatment of metastatic renal cell carcinoma consists in tyrosine kinase inhibitors (TKIs) targ...

全面介紹

書目詳細資料

發表在:	Drug Design, Development and Therapy
Main Authors:	Bellesoeur A, Carton E, Alexandre J, Goldwasser F, Huillard O
格式:	Article
語言:	英语
出版:	Dove Medical Press 2017-09-01
主題:	renal cell carcinoma tyrosine kinase inhibitors vascular endothelial growth factor axitinib pharmacology
在線閱讀:	https://www.dovepress.com/axitinib-in-the-treatment-of-renal-cell-carcinoma-design-development-a-peer-reviewed-article-DDDT